Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
World Neurosurg ; 103: 315-321, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28433849

ABSTRACT

OBJECTIVE: To assess the incidence of cerebrospinal fluid (CSF) leak and meningitis, and the need for prophylactic antibiotics, antipneumococcal vaccination, and surgical interventions, in children with a skull base fracture. METHODS: We reviewed the records of children with a skull base fracture who were admitted to our tertiary care center between 2009 and 2014. RESULTS: A total of 196 children (153 males), age 1 month to 18 years (mean age, 6 ± 4 years), were hospitalized with skull base fracture. Causes of injury were falls (n = 143), motor vehicle accidents (n = 34), and other (n = 19). Fracture locations were the middle skull base in 112 patients, frontal base in 62, and occipital base in 13. Fifty-four children (28%) had a CSF leak. In 34 of these children (63%), spontaneous resolution occurred within 3 days. Three children underwent surgery on admission owing to a CSF leak from an open wound, 3 underwent CSF diversion by spinal drainage, and 4 (2%) required surgery to repair a dural tear after failure of continuous spinal drainage and acetazolamide treatment. Twenty-eight children (14%) received prophylactic antibiotic therapy, usually due to other injuries, and 11 received pneumococcal vaccination. Two children developed meningitis, and 3 children died. Long-term follow up in 124 children revealed 12 children with delayed hearing loss and 3 with delayed facial paralysis. CONCLUSIONS: This is the largest pediatric series of skull base fractures reporting rates of morbidity and long-term outcomes published to date. The rate of meningitis following skull base fracture in children is low, supporting a policy of not administering prophylactic antibiotics or pneumococcal vaccine. Long-term follow up is important to identify delayed complications.


Subject(s)
Acetazolamide/therapeutic use , Anti-Bacterial Agents/therapeutic use , Carbonic Anhydrase Inhibitors/therapeutic use , Cerebrospinal Fluid Leak/epidemiology , Meningitis/epidemiology , Pneumococcal Infections/prevention & control , Pneumococcal Vaccines/therapeutic use , Skull Base/injuries , Skull Fracture, Basilar/therapy , Accidental Falls , Accidents, Traffic , Adolescent , Cerebrospinal Fluid Leak/drug therapy , Cerebrospinal Fluid Leak/etiology , Child , Child, Preschool , Craniocerebral Trauma , Disease Management , Facial Paralysis/epidemiology , Facial Paralysis/etiology , Female , Follow-Up Studies , Glasgow Outcome Scale , Hearing Loss/epidemiology , Hearing Loss/etiology , Humans , Infant , Male , Meningitis/etiology , Retrospective Studies , Skull Base/diagnostic imaging , Skull Fracture, Basilar/complications , Skull Fracture, Basilar/diagnostic imaging , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...